Comparison 4. Long‐term antiplatelet therapy (cilostazol versus aspirin).

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
4.1 All major adverse cardiovascular events (MACE)	1	288	Risk Ratio (M‐H, Fixed, 95% CI)	1.33 [0.74, 2.40]
4.2 Death	1	288	Risk Ratio (M‐H, Fixed, 95% CI)	1.65 [0.55, 4.91]
4.3 Ischaemic stroke	1	288	Risk Ratio (M‐H, Fixed, 95% CI)	0.95 [0.45, 2.01]
4.4 Myocardial infarction	1	288	Risk Ratio (M‐H, Fixed, 95% CI)	11.31 [0.63, 202.63]
4.5 Intracerebral haemorrhage	1	288	Risk Ratio (M‐H, Fixed, 95% CI)	1.29 [0.35, 4.69]
4.6 Vascular death	1	288	Odds Ratio (M‐H, Fixed, 95% CI)	7.35 [0.38, 143.61]
4.7 Any stroke (ischaemic or haemorrhagic)	1	288	Risk Ratio (M‐H, Fixed, 95% CI)	0.97 [0.51, 1.84]